In recent news regarding
Teleflex Incorporated (TFX), multiple hedge funds and investment firms have adjusted their holdings in the company. For instance,
Clearbridge Investments LLC and
Commonwealth Equity Services LLC have sold shares, while firms like
Mackenzie Financial Corp and
Sei Investments Co. have expanded their stake. Teleflex has made quite several announcements, one being its
Second Quarter 2024 Earnings Conference Call, and their
Second Quarter Financial Results, which is in line with its full-year outlook. In terms of performance, Teleflex's
Urolift continues to grow market share, despite macroeconomic challenges. The
Barrigel Rectal Spacer will further be featured at the 2024 American Society for Radiation Oncology Annual Meeting. The corporation recently awarded an agreement with
Premier Inc for hemostasis products and has reported Q2 earnings beating estimates. Meanwhile, the company has approved a
$500M share repurchase program, immediately followed by a share price increase. The company's earning power has been recognised by the market players endorsing the company's stock potentials despite some concerns about long-term profitability due to the past years' results.
Teleflex Incorporated TFX News Analytics from Fri, 02 Dec 2016 08:00:00 GMT to Sat, 05 Oct 2024 12:49:24 GMT -
Rating 3
- Innovation -3
- Information 8
- Rumor -4